NFE2L2 and head and neck squamous cell carcinoma: In HNSCC, tumoral NFE2L2 mutations leading to stronger NRF2 activation were associated with higher locoregional recurrence after treatment with surgery and adjuvant (chemo)radiotherapy, but not after surgery alone [18].